BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, April 3, 2026
Home
»
Topics
» Dermatologic, BioWorld Science
Dermatologic, BioWorld Science
RSS
Cellegy accelerates filing for Anogesic in Canada
Feb. 21, 2001
Protopic for severe atopic dermatitis launched in U.S.
Feb. 20, 2001
Phase II trial establishes safety and optimal dose of PVAC psoriasis treatment
Feb. 19, 2001
Switch Biotech acquires delivery system for skin wounds
Feb. 15, 2001
In vitro study provides support for development of CS-891 as Rx for alopecia
Feb. 9, 2001
Phenyl ureas for the treatment of chemokine-mediated diseases
Feb. 8, 2001
Bridge Pharma/Immune Network alliance selects candidate for atopic dermatitis
Feb. 8, 2001
Vasogen prepares Canadian trial of VAS-972 for psoriasis
Feb. 2, 2001
IDEC-131 commences phase II trial for psoriasis
Jan. 30, 2001
Isotechnika's ISAtx-247 to be developed for third indication: psoriasis
Jan. 26, 2001
Previous
1
2
…
335
336
337
338
339
340
341
342
343
…
416
417
Next
RSS